CAS: 936940-09-9 - (1-isopropyl-1H-pyrazol-4-yl)methanamine
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (1-Isopropyl-1H-pyrazol-4-yl)methanamine REF: IN-DA00H1UQCAS: 936940-09-9 | 95% | 44.00 €~139.00 € | Fri 07 Feb 25 |
 | (1-Isopropyl-1H-pyrazol-4-yl)methanamine REF: 54-OR83266CAS: 936940-09-9 | 95% | 116.00 €~1,648.00 € | Mon 10 Feb 25 |
 | [(1-isopropyl-1H-pyrazol-4-yl)methyl]amine REF: 10-F308882CAS: 936940-09-9 | 95.0% | To inquire | Tue 18 Feb 25 |
 | [(1-Isopropyl-1H-pyrazol-4-yl)methyl]amine REF: 3D-FI123577CAS: 936940-09-9 | Min. 95% | - - - | Discontinued product |
(1-Isopropyl-1H-pyrazol-4-yl)methanamine
CAS:936940-09-9
Formula:
C7H13N3
Purity:
95%
Color and Shape:
Liquid
Molecular weight:
139.1982
Ref: IN-DA00H1UQ
| 1g | 139.00 € | ||
| 100mg | 44.00 € | ||
| 250mg | 67.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
Ref: 54-OR83266
| 1g | 269.00 € | ||
| 5g | 1,020.00 € | ||
| 10g | 1,648.00 € | ||
| 250mg | 116.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
![[(1-isopropyl-1H-pyrazol-4-yl)methyl]amine](https://static.cymitquimica.com/products/10/thumb/F308882.jpg)
[(1-isopropyl-1H-pyrazol-4-yl)methyl]amine
CAS:936940-09-9
Purity:
95.0%
Molecular weight:
139.20199584960938
Ref: 10-F308882
| 1g | 146.00 € | ||
| 5g | To inquire | ||
| 100mg | 23.00 € | ||
| 250mg | 53.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
![[(1-Isopropyl-1H-pyrazol-4-yl)methyl]amine](https://static.cymitquimica.com/products/3D/thumb/FI123577.jpg)
[(1-Isopropyl-1H-pyrazol-4-yl)methyl]amine
CAS:936940-09-9
Please enquire for more information about [(1-Isopropyl-1H-pyrazol-4-yl)methyl]amine including the price, delivery time and more detailed …
Formula:
C7H13N3
Purity:
Min. 95%
Molecular weight:
139.2 g/mol
Ref: 3D-FI123577
| 1g | Discontinued | Request information | |
| 2g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
